Exact Mass: 1055.3382

Exact Mass Matches: 1055.3382

Found 44 metabolites which its exact mass value is equals to given mass value 1055.3382, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

8Z,11Z,14Z-eicosatrienoyl-CoA

{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-{[2-({2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoylsulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}-2,2-dimethylpropoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid

C41H68N7O17P3S (1055.3605)


8Z,11Z,14Z-eicosatrienoyl-CoA participates in the biosynthesis of unsaturated fatty acids. 8Z,11Z,14Z-eicosatrienoyl-CoA is converted from (8Z,11Z,14Z)-Icosatrienoic acid via palmitoyl-CoA hydrolase [EC:3.1.2.2].

Unsaturated fatty acids are of similar form, except that one or more alkenyl functional groups exist along the chain, with each alkene substituting a single-bonded "-CH2-CH2-" part of the chain with a double-bonded "-CH=CH-" portion (that is, a carbon double-bonded to another carbon). The differences in geometry between the various types of unsaturated fatty acids, as well as between saturated and unsaturated fatty acids, play an important role in biological processes, and in the construction of biological structures (such as cell membranes). (Wikipedia)

.

8Z,11Z,14Z-eicosatrienoyl-CoA participates in the biosynthesis of unsaturated fatty acids. 8Z,11Z,14Z-eicosatrienoyl-CoA is converted from (8Z,11Z,14Z)-Icosatrienoic acid via palmitoyl-CoA hydrolase [EC:3.1.2.2].

   

11Z,14Z,17Z-eicosatrienoyl-CoA

(2R)-4-({[({[(2R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-[2-({2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoylsulfanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidic acid

C41H68N7O17P3S (1055.3605)


11Z,14Z,17Z-eicosatrienoyl-CoA is classified as a member of the Long-chain fatty acyl CoAs. Long-chain fatty acyl CoAs are acyl CoAs where the group acylated to the coenzyme A moiety is a long aliphatic chain of 13 to 21 carbon atoms. 11Z,14Z,17Z-eicosatrienoyl-CoA is considered to be practically insoluble (in water) and acidic. 11Z,14Z,17Z-eicosatrienoyl-CoA is a fatty ester lipid molecule

   

sciadonoyl-CoA

(5Z,11Z,14Z)-icosatrienoyl-CoA

C41H68N7O17P3S (1055.3605)


   

5Z,8Z,11Z-eicosatrienoyl-CoA

(2R)-4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-[2-({2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoylsulphanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidic acid

C41H68N7O17P3S (1055.3605)


5Z,8Z,11Z-eicosatrienoyl-CoA is classified as a member of the Long-chain fatty acyl CoAs. Long-chain fatty acyl CoAs are acyl CoAs where the group acylated to the coenzyme A moiety is a long aliphatic chain of 13 to 21 carbon atoms. 5Z,8Z,11Z-eicosatrienoyl-CoA is considered to be practically insoluble (in water) and acidic. 5Z,8Z,11Z-eicosatrienoyl-CoA is a fatty ester lipid molecule

   

trans,cis,cis-2,11,14-Eicosatrienoyl-CoA

(2R)-4-({[({[(2S,3S,4R,5S)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-[2-({2-[(2E,11Z,14Z)-icosa-2,11,14-trienoylsulfanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidic acid

C41H68N7O17P3S (1055.3605)


This compound belongs to the family of Acyl CoAs. These are organic compounds contaning a coenzyme A substructure linked to another moeity through an ester bond.

   

Icosa-8,11,14-trienoyl-CoA

4-({[({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-(2-{[2-(icosa-8,11,14-trienoylsulphanyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)-3,3-dimethylbutanimidic acid

C41H68N7O17P3S (1055.3605)


Icosa-8,11,14-trienoyl-coa is an acyl-CoA or acyl-coenzyme A. More specifically, it is an icosa-8_11_14-trienoic acid thioester of coenzyme A. Icosa-8,11,14-trienoyl-coa is an acyl-CoA with 20 fatty acid group as the acyl moiety attached to coenzyme A. Coenzyme A was discovered in 1946 by Fritz Lipmann (Journal of Biological Chemistry (1946) 162 (3): 743–744) and its structure was determined in the early 1950s at the Lister Institute in London. Coenzyme A is a complex, thiol-containing molecule that is naturally synthesized from pantothenate (vitamin B5), which is found in various foods such as meat, vegetables, cereal grains, legumes, eggs, and milk. More specifically, coenzyme A (CoASH or CoA) consists of a beta-mercaptoethylamine group linked to the vitamin pantothenic acid (B5) through an amide linkage and 3-phosphorylated ADP. Coenzyme A is synthesized in a five-step process that requires four molecules of ATP, pantothenate and cysteine. It is believed that there are more than 1100 types of acyl-CoA’s in the human body, which also corresponds to the number of acylcarnitines in the human body. Acyl-CoAs exists in all living species, ranging from bacteria to plants to humans. The general role of acyl-CoA’s is to assist in transferring fatty acids from the cytoplasm to mitochondria. This process facilitates the production of fatty acids in cells, which are essential in cell membrane structure. Acyl-CoAs are also susceptible to beta oxidation, forming, ultimately, acetyl-CoA. Acetyl-CoA can enter the citric acid cycle, eventually forming several equivalents of ATP. In this way, fats are converted to ATP -- or biochemical energy. Acyl-CoAs can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain acyl-CoAs; 2) medium-chain acyl-CoAs; 3) long-chain acyl-CoAs; and 4) very long-chain acyl-CoAs; 5) hydroxy acyl-CoAs; 6) branched chain acyl-CoAs; 7) unsaturated acyl-CoAs; 8) dicarboxylic acyl-CoAs and 9) miscellaneous acyl-CoAs. Short-chain acyl-CoAs have acyl-groups with two to four carbons (C2-C4), medium-chain acyl-CoAs have acyl-groups with five to eleven carbons (C5-C11), long-chain acyl-CoAs have acyl-groups with twelve to twenty carbons (C12-C20) while very long-chain acyl-CoAs have acyl groups with more than 20 carbons. Icosa-8,11,14-trienoyl-coa is therefore classified as a long chain acyl-CoA. The oxidative degradation of fatty acids is a two-step process, catalyzed by acyl-CoA synthetase/synthase. Fatty acids are first converted to their acyl phosphate, the precursor to acyl-CoA. The latter conversion is mediated by acyl-CoA synthase. Three types of acyl-CoA synthases are employed, depending on the chain length of the fatty acid. Icosa-8,11,14-trienoyl-coa, being a long chain acyl-CoA is a substrate for long chain acyl-CoA synthase. The second step of fatty acid degradation is beta oxidation. Beta oxidation occurs in mitochondria and, in the case of very long chain acyl-CoAs, the peroxisome. After its formation in the cytosol, Icosa-8,11,14-trienoyl-CoA is transported into the mitochondria, the locus of beta oxidation. Transport of Icosa-8,11,14-trienoyl-CoA into the mitochondria requires carnitine palmitoyltransferase 1 (CPT1), which converts Icosa-8,11,14-trienoyl-CoA into Icosa-8_11_14-trienoylcarnitine, which gets transported into the mitochondrial matrix. Once in the matrix, Icosa-8_11_14-trienoylcarnitine is converted back to Icosa-8,11,14-trienoyl-CoA by CPT2, whereupon beta-oxidation can begin. Beta oxidation of Icosa-8,11,14-trienoyl-CoA occurs in four steps. First, since Icosa-8,11,14-trienoyl-CoA is a long chain acyl-CoA it is the substrate for a long chain acyl-CoA dehydrogenase, which catalyzes dehydrogenation of Icosa-8,11,14-trienoyl-CoA, creating a double bond between the alpha and beta carbons. FAD is the hydrogen acceptor, yielding FADH2. Second, Enoyl-CoA hydrase catalyzes the addition of water across the newly formed double bond to make an alcohol. Third, ...

   

Icosa-5,8,11-trienoyl-CoA

4-({[({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-(2-{[2-(icosa-5,8,11-trienoylsulphanyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)-3,3-dimethylbutanimidic acid

C41H68N7O17P3S (1055.3605)


Icosa-5,8,11-trienoyl-coa is an acyl-CoA or acyl-coenzyme A. More specifically, it is an icosa-5_8_11-trienoic acid thioester of coenzyme A. Icosa-5,8,11-trienoyl-coa is an acyl-CoA with 20 fatty acid group as the acyl moiety attached to coenzyme A. Coenzyme A was discovered in 1946 by Fritz Lipmann (Journal of Biological Chemistry (1946) 162 (3): 743–744) and its structure was determined in the early 1950s at the Lister Institute in London. Coenzyme A is a complex, thiol-containing molecule that is naturally synthesized from pantothenate (vitamin B5), which is found in various foods such as meat, vegetables, cereal grains, legumes, eggs, and milk. More specifically, coenzyme A (CoASH or CoA) consists of a beta-mercaptoethylamine group linked to the vitamin pantothenic acid (B5) through an amide linkage and 3-phosphorylated ADP. Coenzyme A is synthesized in a five-step process that requires four molecules of ATP, pantothenate and cysteine. It is believed that there are more than 1100 types of acyl-CoA’s in the human body, which also corresponds to the number of acylcarnitines in the human body. Acyl-CoAs exists in all living species, ranging from bacteria to plants to humans. The general role of acyl-CoA’s is to assist in transferring fatty acids from the cytoplasm to mitochondria. This process facilitates the production of fatty acids in cells, which are essential in cell membrane structure. Acyl-CoAs are also susceptible to beta oxidation, forming, ultimately, acetyl-CoA. Acetyl-CoA can enter the citric acid cycle, eventually forming several equivalents of ATP. In this way, fats are converted to ATP -- or biochemical energy. Acyl-CoAs can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain acyl-CoAs; 2) medium-chain acyl-CoAs; 3) long-chain acyl-CoAs; and 4) very long-chain acyl-CoAs; 5) hydroxy acyl-CoAs; 6) branched chain acyl-CoAs; 7) unsaturated acyl-CoAs; 8) dicarboxylic acyl-CoAs and 9) miscellaneous acyl-CoAs. Short-chain acyl-CoAs have acyl-groups with two to four carbons (C2-C4), medium-chain acyl-CoAs have acyl-groups with five to eleven carbons (C5-C11), long-chain acyl-CoAs have acyl-groups with twelve to twenty carbons (C12-C20) while very long-chain acyl-CoAs have acyl groups with more than 20 carbons. Icosa-5,8,11-trienoyl-coa is therefore classified as a long chain acyl-CoA. The oxidative degradation of fatty acids is a two-step process, catalyzed by acyl-CoA synthetase/synthase. Fatty acids are first converted to their acyl phosphate, the precursor to acyl-CoA. The latter conversion is mediated by acyl-CoA synthase. Three types of acyl-CoA synthases are employed, depending on the chain length of the fatty acid. Icosa-5,8,11-trienoyl-coa, being a long chain acyl-CoA is a substrate for long chain acyl-CoA synthase. The second step of fatty acid degradation is beta oxidation. Beta oxidation occurs in mitochondria and, in the case of very long chain acyl-CoAs, the peroxisome. After its formation in the cytosol, Icosa-5,8,11-trienoyl-CoA is transported into the mitochondria, the locus of beta oxidation. Transport of Icosa-5,8,11-trienoyl-CoA into the mitochondria requires carnitine palmitoyltransferase 1 (CPT1), which converts Icosa-5,8,11-trienoyl-CoA into Icosa-5_8_11-trienoylcarnitine, which gets transported into the mitochondrial matrix. Once in the matrix, Icosa-5_8_11-trienoylcarnitine is converted back to Icosa-5,8,11-trienoyl-CoA by CPT2, whereupon beta-oxidation can begin. Beta oxidation of Icosa-5,8,11-trienoyl-CoA occurs in four steps. First, since Icosa-5,8,11-trienoyl-CoA is a long chain acyl-CoA it is the substrate for a long chain acyl-CoA dehydrogenase, which catalyzes dehydrogenation of Icosa-5,8,11-trienoyl-CoA, creating a double bond between the alpha and beta carbons. FAD is the hydrogen acceptor, yielding FADH2. Second, Enoyl-CoA hydrase catalyzes the addition of water across the newly formed double bond to make an alcohol. Third, 3-hydroxyacyl-...

   

(11Z,14Z,17Z)-icosa-11,14,17-trienoyl-CoA

4-({[({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-(2-{[2-(icosa-11,14,17-trienoylsulphanyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)-3,3-dimethylbutanimidic acid

C41H68N7O17P3S (1055.3605)


(11z,14z,17z)-icosa-11,14,17-trienoyl-coa is an acyl-CoA or acyl-coenzyme A. More specifically, it is a (11Z_14Z_17Z)-icosa-11_14_17-trienoic acid thioester of coenzyme A. (11z,14z,17z)-icosa-11,14,17-trienoyl-coa is an acyl-CoA with 20 fatty acid group as the acyl moiety attached to coenzyme A. Coenzyme A was discovered in 1946 by Fritz Lipmann (Journal of Biological Chemistry (1946) 162 (3): 743–744) and its structure was determined in the early 1950s at the Lister Institute in London. Coenzyme A is a complex, thiol-containing molecule that is naturally synthesized from pantothenate (vitamin B5), which is found in various foods such as meat, vegetables, cereal grains, legumes, eggs, and milk. More specifically, coenzyme A (CoASH or CoA) consists of a beta-mercaptoethylamine group linked to the vitamin pantothenic acid (B5) through an amide linkage and 3-phosphorylated ADP. Coenzyme A is synthesized in a five-step process that requires four molecules of ATP, pantothenate and cysteine. It is believed that there are more than 1100 types of acyl-CoA’s in the human body, which also corresponds to the number of acylcarnitines in the human body. Acyl-CoAs exists in all living species, ranging from bacteria to plants to humans. The general role of acyl-CoA’s is to assist in transferring fatty acids from the cytoplasm to mitochondria. This process facilitates the production of fatty acids in cells, which are essential in cell membrane structure. Acyl-CoAs are also susceptible to beta oxidation, forming, ultimately, acetyl-CoA. Acetyl-CoA can enter the citric acid cycle, eventually forming several equivalents of ATP. In this way, fats are converted to ATP -- or biochemical energy. Acyl-CoAs can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain acyl-CoAs; 2) medium-chain acyl-CoAs; 3) long-chain acyl-CoAs; and 4) very long-chain acyl-CoAs; 5) hydroxy acyl-CoAs; 6) branched chain acyl-CoAs; 7) unsaturated acyl-CoAs; 8) dicarboxylic acyl-CoAs and 9) miscellaneous acyl-CoAs. Short-chain acyl-CoAs have acyl-groups with two to four carbons (C2-C4), medium-chain acyl-CoAs have acyl-groups with five to eleven carbons (C5-C11), long-chain acyl-CoAs have acyl-groups with twelve to twenty carbons (C12-C20) while very long-chain acyl-CoAs have acyl groups with more than 20 carbons. (11z,14z,17z)-icosa-11,14,17-trienoyl-coa is therefore classified as a long chain acyl-CoA. The oxidative degradation of fatty acids is a two-step process, catalyzed by acyl-CoA synthetase/synthase. Fatty acids are first converted to their acyl phosphate, the precursor to acyl-CoA. The latter conversion is mediated by acyl-CoA synthase. Three types of acyl-CoA synthases are employed, depending on the chain length of the fatty acid. (11z,14z,17z)-icosa-11,14,17-trienoyl-coa, being a long chain acyl-CoA is a substrate for long chain acyl-CoA synthase. The second step of fatty acid degradation is beta oxidation. Beta oxidation occurs in mitochondria and, in the case of very long chain acyl-CoAs, the peroxisome. After its formation in the cytosol, (11Z,14Z,17Z)-icosa-11,14,17-trienoyl-CoA is transported into the mitochondria, the locus of beta oxidation. Transport of (11Z,14Z,17Z)-icosa-11,14,17-trienoyl-CoA into the mitochondria requires carnitine palmitoyltransferase 1 (CPT1), which converts (11Z,14Z,17Z)-icosa-11,14,17-trienoyl-CoA into (11Z_14Z_17Z)-icosa-11_14_17-trienoylcarnitine, which gets transported into the mitochondrial matrix. Once in the matrix, (11Z_14Z_17Z)-icosa-11_14_17-trienoylcarnitine is converted back to (11Z,14Z,17Z)-icosa-11,14,17-trienoyl-CoA by CPT2, whereupon beta-oxidation can begin. Beta oxidation of (11Z,14Z,17Z)-icosa-11,14,17-trienoyl-CoA occurs in four steps. First, since (11Z,14Z,17Z)-icosa-11,14,17-trienoyl-CoA is a long chain acyl-CoA it is the substrate for a long chain acyl-CoA dehydrogenase, which catalyzes dehydrogenation of (11Z,14Z,17Z)-icosa-11,14,17-trienoyl-CoA, creating a double...

   
   

11Z,14Z,17Z-eicosatrienoyl-CoA

11Z,14Z,17Z-eicosatrienoyl-CoA

C41H68N7O17P3S (1055.3605)


   

5Z,8Z,11Z-eicosatrienoyl-CoA

5Z,8Z,11Z-eicosatrienoyl-CoA

C41H68N7O17P3S (1055.3605)


   

CoA 20:3

(8Z,11Z,14Z)-eicosatrienoyl-coenzyme A;8Z,11Z,14Z-eicosatrienoyl-CoA;8Z,11Z,14Z-icosatrienoyl-CoA;CoA[20:3(8Z,11Z,14Z)];all-cis-eicosa-8,11,14-trienoyl-CoA;all-cis-eicosa-8,11,14-trienoyl-coenzyme A;all-cis-icosa-8,11,14-trienoyl-CoA;all-cis-icosa-8,11,14-trienoyl-coenzyme A

C41H68N7O17P3S (1055.3605)


   
   
   
   
   

(2E,11Z,14Z)-icosatrienoyl-CoA

(2E,11Z,14Z)-icosatrienoyl-CoA

C41H68N7O17P3S (1055.3605)


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (2E,11Z,14Z)-icosatrienoic acid.

   

Icosa-8,11,14-trienoyl-CoA

Icosa-8,11,14-trienoyl-CoA

C41H68N7O17P3S (1055.3605)


   

Icosa-5,8,11-trienoyl-CoA

Icosa-5,8,11-trienoyl-CoA

C41H68N7O17P3S (1055.3605)


   

S-[2-[3-[[4-[[[5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (11E,14E,17E)-icosa-11,14,17-trienethioate

S-[2-[3-[[4-[[[5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (11E,14E,17E)-icosa-11,14,17-trienethioate

C41H68N7O17P3S (1055.3605)


   
   

NeuGc(a2-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]a-GalNAc

NeuGc(a2-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]a-GalNAc

C39H65N3O30 (1055.3653)


   

NeuGc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)GalNAc

NeuGc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)GalNAc

C39H65N3O30 (1055.3653)


   

Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)[NeuGc(a2-6)]GalNAc

Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)[NeuGc(a2-6)]GalNAc

C39H65N3O30 (1055.3653)


   

NeuGc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)a-GalNAc

NeuGc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)a-GalNAc

C39H65N3O30 (1055.3653)


   

Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)[NeuGc(a2-6)]a-GalNAc

Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)[NeuGc(a2-6)]a-GalNAc

C39H65N3O30 (1055.3653)


   

NeuGc(a2-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc

NeuGc(a2-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc

C39H65N3O30 (1055.3653)


   

NeuGc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]a-GalNAc

NeuGc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]a-GalNAc

C39H65N3O30 (1055.3653)


   

8,11,14-Eicosatrienoyl-CoA; (Acyl-CoA); [M+H]+

8,11,14-Eicosatrienoyl-CoA; (Acyl-CoA); [M+H]+

C41H68N7O17P3S (1055.3605)


   

Ferrichrome A [M+Fe-2H]

Ferrichrome A [M+Fe-2H]

C41H61FeN9O20 (1055.3382)


   

(11Z,14Z,17Z)-Icosatrienoyl-CoA; (Acyl-CoA); [M+H]+

(11Z,14Z,17Z)-Icosatrienoyl-CoA; (Acyl-CoA); [M+H]+

C41H68N7O17P3S (1055.3605)


   

8Z,11Z,14Z-eicosatrienoyl-CoA

all-cis-icosa-8,11,14-trienoyl-CoA

C41H68N7O17P3S (1055.3605)


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of all-cis-icosa-8,11,14-trienoic acid.

   

(5Z,11Z,14Z)-icosatrienoyl-CoA

(5Z,11Z,14Z)-icosatrienoyl-CoA

C41H68N7O17P3S (1055.3605)


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (5Z,11Z,14Z)-icosatrienoic acid.

   

trans-2-icosenoyl-CoA(4-)

trans-2-icosenoyl-CoA(4-)

C41H68N7O17P3S (1055.3605)


An acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of trans-2-icosenoyl-CoA.

   

(11Z,14Z,17Z)-Icosatrienoyl-CoA

(11Z,14Z,17Z)-icosa-11,14,17-trienoyl-CoA

C41H68N7O17P3S (1055.3605)


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (11Z,14Z,17Z)-icosatrienoic acid.

   

(13Z)-icosenoyl-CoA(4-)

(13Z)-icosenoyl-CoA(4-)

C41H68N7O17P3S (1055.3605)


An acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (13Z)-icosenoyl-CoA; major species at pH 7.3.

   

(5Z)-icosenoyl-CoA(4-)

(5Z)-icosenoyl-CoA(4-)

C41H68N7O17P3S (1055.3605)


A monounsaturated fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (5Z)-icosenoyl-CoA; major species at pH 7.3.

   

(11Z)-eicosenoyl-CoA(4-)

(11Z)-eicosenoyl-CoA(4-)

C41H68N7O17P3S (1055.3605)


An acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (11Z)-eicosenoyl-CoA.

   
   

(2r)-n-[(2s,5s,8s,11r,12s,15s,18r,21r)-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-bis(sulfooxy)propanimidic acid

(2r)-n-[(2s,5s,8s,11r,12s,15s,18r,21r)-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-bis(sulfooxy)propanimidic acid

C40H62ClN9O18S2 (1055.3343)


   

(2r)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-2,8-bis[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-bis(sulfooxy)propanimidic acid

(2r)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-2,8-bis[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-bis(sulfooxy)propanimidic acid

C40H62ClN9O18S2 (1055.3343)


   

(2s)-n-[(2s,5r,8r,11s,12s,15r,18s,21s)-2,8-bis[(2r)-butan-2-yl]-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-bis(sulfooxy)propanimidic acid

(2s)-n-[(2s,5r,8r,11s,12s,15r,18s,21s)-2,8-bis[(2r)-butan-2-yl]-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-bis(sulfooxy)propanimidic acid

C40H62ClN9O18S2 (1055.3343)


   

n-[15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-bis(sulfooxy)propanimidic acid

n-[15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-bis(sulfooxy)propanimidic acid

C40H62ClN9O18S2 (1055.3343)


   

(2r)-4-[({[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-2-hydroxy-n-[2-({2-[(11z,14z,17z)-icosa-11,14,17-trienoylsulfanyl]ethyl}-c-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidic acid

(2r)-4-[({[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-2-hydroxy-n-[2-({2-[(11z,14z,17z)-icosa-11,14,17-trienoylsulfanyl]ethyl}-c-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidic acid

C41H68N7O17P3S (1055.3605)